Cancer innovation

Keyphrases

Publications

volume 3, number 2, 2024

Shilpa Malakar, Emmanuel Nuah Gontor, Moses Y Dugbaye, Kamal Shah, Sakshi Sinha, Priya Sutaoney, Nagendra Singh Chauhan
Cancer treatment with biosimilar drugs: A review. Cancer innovation 3 (2) (2024)
Satoru Sasagawa, Jun Kumai, Toru Wakamatsu, Yoshihiro Yui
Improvement of histone deacetylase inhibitor efficacy by SN38 through TWIST1 suppression in synovial sarcoma. Cancer innovation 3 (2) (2024)
Xueqi Chen, Jiayin Shou, Shanshi Li, Yan Fan, Jianhua Zhang
18 F-FDG PET/CT findings of paratesticular alveolar rhabdomyosarcoma. Cancer innovation 3 (2) (2024)
Yi Zheng, Ying Liu, Ziliang Chen, Yunpeng Zhang, Zuo Qi, Ning Wu, Zhiqiang Zhao, Gary Tse, Yong Wang, Hailong Hu, Yuanjie Niu, Tong Liu
Cardiovascular disease burden in patients with urological cancers: The new discipline of uro-cardio-oncology. Cancer innovation 3 (2) (2024)
Xueqi Chen, Jiayin Shou, Shanshi Li, Yan Fan, Jianhua Zhang
18 F-FDG PET/CT findings of paratesticular alveolar rhabdomyosarcoma. Cancer innovation 3 (2) (2024)
Na Sun, Cheng Wang, Pingping Gao, Rui Wang, Yi Zhang, Xiaowei Qi
Multifaceted roles and functions of SOX30 in human cancer. Cancer innovation 3 (2) (2024)
Shilpa Malakar, Emmanuel Nuah Gontor, Moses Y Dugbaye, Kamal Shah, Sakshi Sinha, Priya Sutaoney, Nagendra Singh Chauhan
Cancer treatment with biosimilar drugs: A review. Cancer innovation 3 (2) (2024)
Satoru Sasagawa, Jun Kumai, Toru Wakamatsu, Yoshihiro Yui
Improvement of histone deacetylase inhibitor efficacy by SN38 through TWIST1 suppression in synovial sarcoma. Cancer innovation 3 (2) (2024)
Na Sun, Cheng Wang, Pingping Gao, Rui Wang, Yi Zhang, Xiaowei Qi
Multifaceted roles and functions of SOX30 in human cancer. Cancer innovation 3 (2) (2024)

volume 3, number 3, 2024

Lu Peng, Yuan Gao, Zifeng Cao, Yingxin Pang
Identification of a disulfidptosis-related prognostic signature for prediction of the effect of treatment in patients with endometrial carcinoma. Cancer innovation 3 (3) (2024)
Sahil Seth, Runzhe Chen, Yang Liu, Junya Fujimoto, Lingzhi Hong, Alexandre Reuben, Susan Varghese, Carmen Behrens, Tina McDowell, Luisa Solis Soto, Cara Haymaker, Annikka Weissferdt, Neda Kalhor, Jia Wu, Xiuning Le, Natalie I Vokes, Chao Cheng, John V Heymach, Don L Gibbons, P Andrew Futreal, Ignacio I Wistuba, Humam Kadara, Jianhua Zhang, Cesar Moran, Jianjun Zhang
Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomes. Cancer innovation 3 (3) (2024)
Ya-Xi Wu, Bing-Qian Li, Xiao-Qian Yu, Yu-Lin Liu, Rui-Hao Chui, Kai Sun, Dian-Guang Geng, Li-Ying Ma
Histone deacetylase 6 as a novel promising target to treat cardiovascular disease. Cancer innovation 3 (3) (2024)
Enzhao Zhu, Linmei Zhang, Jiayi Wang, Chunyu Hu, Qi Jing, Weizhong Shi, Ziqin Xu, Pu Ai, Zhihao Dai, Dan Shan, Zisheng Ai
Personalized surgical recommendations and quantitative therapeutic insights for patients with metastatic breast cancer: Insights from deep learning. Cancer innovation 3 (3) (2024)
Enzhao Zhu, Linmei Zhang, Jiayi Wang, Chunyu Hu, Qi Jing, Weizhong Shi, Ziqin Xu, Pu Ai, Zhihao Dai, Dan Shan, Zisheng Ai
Personalized surgical recommendations and quantitative therapeutic insights for patients with metastatic breast cancer: Insights from deep learning. Cancer innovation 3 (3) (2024)
Yulin Xu, Wei Shan, Qian Luo, Meng Zhang, Dawei Huo, Yijin Chen, Honghu Li, Yi-Shan Ye, Xiaohong Yu, Yi Luo, He Huang
Establishment of a humanized mouse model using steady-state peripheral blood-derived hematopoietic stem and progenitor cells facilitates screening of cancer-targeted T-cell repertoires. Cancer innovation 3 (3) (2024)
Huiyi Liu, Lu Fu, Shuyu Jin, Xingdong Ye, Yanlin Chen, Sijia Pu, Yumei Xue
Cardiovascular toxicity with CTLA-4 inhibitors in cancer patients: A meta-analysis. Cancer innovation 3 (3) (2024)
Lu Peng, Yuan Gao, Zifeng Cao, Yingxin Pang
Identification of a disulfidptosis-related prognostic signature for prediction of the effect of treatment in patients with endometrial carcinoma. Cancer innovation 3 (3) (2024)
Jing Chen, Jing Yang, Yufang Liu, Xu Zhao, Juanjuan Zhao, Lin Tang, Mengmeng Guo, Ya Zhou, Chao Chen, Dongmei Li, Zhenke Wen, Guiyou Liang, Lin Xu
MAPK4 facilitates angiogenesis by inhibiting the ERK pathway in non-small cell lung cancer. Cancer innovation 3 (3) (2024)
Wenhua Song, Nan Zhang, Tonglian Lv, Yang Zhao, Guangping Li, Gary Tse, Tong Liu
Prognostic value of cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis: A systematic review and meta-analysis. Cancer innovation 3 (3) (2024)
Sahil Seth, Runzhe Chen, Yang Liu, Junya Fujimoto, Lingzhi Hong, Alexandre Reuben, Susan Varghese, Carmen Behrens, Tina McDowell, Luisa Solis Soto, Cara Haymaker, Annikka Weissferdt, Neda Kalhor, Jia Wu, Xiuning Le, Natalie I Vokes, Chao Cheng, John V Heymach, Don L Gibbons, P Andrew Futreal, Ignacio I Wistuba, Humam Kadara, Jianhua Zhang, Cesar Moran, Jianjun Zhang
Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomes. Cancer innovation 3 (3) (2024)
Ya-Xi Wu, Bing-Qian Li, Xiao-Qian Yu, Yu-Lin Liu, Rui-Hao Chui, Kai Sun, Dian-Guang Geng, Li-Ying Ma
Histone deacetylase 6 as a novel promising target to treat cardiovascular disease. Cancer innovation 3 (3) (2024)
Yulin Xu, Wei Shan, Qian Luo, Meng Zhang, Dawei Huo, Yijin Chen, Honghu Li, Yi-Shan Ye, Xiaohong Yu, Yi Luo, He Huang
Establishment of a humanized mouse model using steady-state peripheral blood-derived hematopoietic stem and progenitor cells facilitates screening of cancer-targeted T-cell repertoires. Cancer innovation 3 (3) (2024)
Wenhua Song, Nan Zhang, Tonglian Lv, Yang Zhao, Guangping Li, Gary Tse, Tong Liu
Prognostic value of cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis: A systematic review and meta-analysis. Cancer innovation 3 (3) (2024)
Jing Chen, Jing Yang, Yufang Liu, Xu Zhao, Juanjuan Zhao, Lin Tang, Mengmeng Guo, Ya Zhou, Chao Chen, Dongmei Li, Zhenke Wen, Guiyou Liang, Lin Xu
MAPK4 facilitates angiogenesis by inhibiting the ERK pathway in non-small cell lung cancer. Cancer innovation 3 (3) (2024)
Huiyi Liu, Lu Fu, Shuyu Jin, Xingdong Ye, Yanlin Chen, Sijia Pu, Yumei Xue
Cardiovascular toxicity with CTLA-4 inhibitors in cancer patients: A meta-analysis. Cancer innovation 3 (3) (2024)

volume 3, number 4, 2024

Boyu Qin, Qi Xiong, Lingli Xin, Ke Li, Weiwei Shi, Qi Song, Qiong Sun, Jiakang Shao, Jing Zhang, Xiao Zhao, Jinyu Liu, Jinliang Wang, Bo Yang
Synergistic effect of additional anlotinib and immunotherapy as second-line or later-line treatment in pancreatic cancer: A retrospective cohort study. Cancer innovation 3 (4) (2024)
Lixi Li, Yun Wu, Bo Lan, Zongbi Yi
Efficacy and safety of first-line regimens for advanced HER2-positive breast cancer: A Bayesian network meta-analysis. Cancer innovation 3 (4) (2024)
Lixi Li, Yun Wu, Bo Lan, Zongbi Yi
Efficacy and safety of first-line regimens for advanced HER2-positive breast cancer: A Bayesian network meta-analysis. Cancer innovation 3 (4) (2024)
Di Zhang, Lixi Li, Zongbi Yi
Integrative analyses identified gap junction beta-2 as a prognostic biomarker and therapeutic target for breast cancer. Cancer innovation 3 (4) (2024)
Wei Chen, Haiyan Zhou, Mingyu Zhang, Yafei Shi, Taifeng Li, Di Qian, Jun Yang, Feng Yu, Guohui Li
Novel progressive deep learning algorithm for uncovering multiple single nucleotide polymorphism interactions to predict paclitaxel clearance in patients with nonsmall cell lung cancer. Cancer innovation 3 (4) (2024)
Boyu Qin, Qi Xiong, Lingli Xin, Ke Li, Weiwei Shi, Qi Song, Qiong Sun, Jiakang Shao, Jing Zhang, Xiao Zhao, Jinyu Liu, Jinliang Wang, Bo Yang
Synergistic effect of additional anlotinib and immunotherapy as second-line or later-line treatment in pancreatic cancer: A retrospective cohort study. Cancer innovation 3 (4) (2024)
Di Zhang, Lixi Li, Zongbi Yi
Integrative analyses identified gap junction beta-2 as a prognostic biomarker and therapeutic target for breast cancer. Cancer innovation 3 (4) (2024)
Yuan-Yuan Sun, Hai-Cheng Gao, Peng Guo, Na Sun, Chan Peng, Zhi-Hua Cheng, Jing Gu, Jin-Yi Liu, Fei Han
Identification of NR3C2 as a functional diagnostic and prognostic biomarker and potential therapeutic target in non-small cell lung cancer. Cancer innovation 3 (4) (2024)
Di Wang, Jing Zhang, Jianchao Wang, Zhonglin Cai, Shanfeng Jin, Gang Chen
Identification of collagen subtypes of gastric cancer for distinguishing patient prognosis and therapeutic response. Cancer innovation 3 (4) (2024)
Wei Chen, Haiyan Zhou, Mingyu Zhang, Yafei Shi, Taifeng Li, Di Qian, Jun Yang, Feng Yu, Guohui Li
Novel progressive deep learning algorithm for uncovering multiple single nucleotide polymorphism interactions to predict paclitaxel clearance in patients with nonsmall cell lung cancer. Cancer innovation 3 (4) (2024)
Yuan-Yuan Sun, Hai-Cheng Gao, Peng Guo, Na Sun, Chan Peng, Zhi-Hua Cheng, Jing Gu, Jin-Yi Liu, Fei Han
Identification of NR3C2 as a functional diagnostic and prognostic biomarker and potential therapeutic target in non-small cell lung cancer. Cancer innovation 3 (4) (2024)
Kaixiang Feng, Youcheng Shao, Jun Li, Xiaoqing Guan, Qin Liu, Meishun Hu, Mengfei Chu, Hui Li, Fangfang Chen, Zong-Bi Yi, Jingwei Zhang
A lactate-responsive gene signature predicts the prognosis and immunotherapeutic response of patients with triple-negative breast cancer. Cancer innovation 3 (4) (2024)
Yihao Wang, Kaixin Yan, Han Duan, Ning Tao, Shaoning Zhu, Yuning Zhang, Yonggang You, Zhen Zhang, Hua Wang, Shunying Hu
High-fat-diet-induced obesity promotes simultaneous progression of lung cancer and atherosclerosis in apolipoprotein E-knockout mice. Cancer innovation 3 (4) (2024)
Yihao Wang, Kaixin Yan, Han Duan, Ning Tao, Shaoning Zhu, Yuning Zhang, Yonggang You, Zhen Zhang, Hua Wang, Shunying Hu
High-fat-diet-induced obesity promotes simultaneous progression of lung cancer and atherosclerosis in apolipoprotein E-knockout mice. Cancer innovation 3 (4) (2024)
Kaixiang Feng, Youcheng Shao, Jun Li, Xiaoqing Guan, Qin Liu, Meishun Hu, Mengfei Chu, Hui Li, Fangfang Chen, Zong-Bi Yi, Jingwei Zhang
A lactate-responsive gene signature predicts the prognosis and immunotherapeutic response of patients with triple-negative breast cancer. Cancer innovation 3 (4) (2024)
Di Wang, Jing Zhang, Jianchao Wang, Zhonglin Cai, Shanfeng Jin, Gang Chen
Identification of collagen subtypes of gastric cancer for distinguishing patient prognosis and therapeutic response. Cancer innovation 3 (4) (2024)

volume 3, number 5, 2024

Xiong Chen, Qinchang Chen, Yuanfang Liu, Ya Qiu, Lin Lv, Zhengtao Zhang, Xuntao Yin, Fangpeng Shu
Radiomics models to predict bone marrow metastasis of neuroblastoma using CT. Cancer innovation 3 (5) (2024)
Rui Wang, Ni-Sha Wu, Li Wang, Zhi-Zhao Zhang, Cheng-Fang Wang, Yan Wang, Yan Liang, Yi Zhang, Xiao-Wei Qi
A pan-cancer analysis of Wnt family member 7B in human cancers. Cancer innovation 3 (5) (2024)
Qiao Li, Dan Lv, Xiaoying Sun, Mengyuan Wang, Li Cai, Feng Liu, Chenghui Li, Jiuda Zhao, Jing Sun, Yehui Shi, Zongbi Yi
Inetetamab combined with sirolimus and chemotherapy for the treatment of HER2-positive metastatic breast cancer patients with abnormal activation of the PI3K/Akt/mTOR pathway after trastuzumab treatment. Cancer innovation 3 (5) (2024)
Hongnan Mo, Ruiqi Zhong, Zongbi Yi
Chinese expert consensus on an innovative patient-centered approach to diagnosis and treatment of cancer. Cancer innovation 3 (5) (2024)
Aixa Medina, Jeismar Carballo, Eglys González-Marcano, Isaac Blanca, Ana F Convit
Breast cancer immunotherapy: Realities and advances. Cancer innovation 3 (5) (2024)
Xuesong Li, Zhuo Yu
Role of liquid-liquid phase separation in cancer: Mechanisms and therapeutic implications. Cancer innovation 3 (5) (2024)
Hongnan Mo, Ruiqi Zhong, Zongbi Yi
Chinese expert consensus on an innovative patient-centered approach to diagnosis and treatment of cancer. Cancer innovation 3 (5) (2024)
Xiong Chen, Qinchang Chen, Yuanfang Liu, Ya Qiu, Lin Lv, Zhengtao Zhang, Xuntao Yin, Fangpeng Shu
Radiomics models to predict bone marrow metastasis of neuroblastoma using CT. Cancer innovation 3 (5) (2024)
Boyue Han, Xiangchen Han, Hong Luo, Javaria Nasir, Chao Chen, Zhiming Shao, Hong Ling, Xin Hu
Multiomics and single-cell sequencings reveal the specific biological characteristics of low Ki-67 triple-negative breast cancer. Cancer innovation 3 (5) (2024)